BACKGROUND: In HIV-infected women, urine concentrations of novel tubulointerstitial injury markers, interleukin-18 (IL-18) and kidney injury marker-1 (KIM-1), are associated with kidney function decline and all-cause mortality. We hypothesized that HIV-infected individuals with preserved kidney filtration function would have more extensive kidney injury, as determined by urine injury markers, compared to the uninfected controls, and that risk factors for tubulointerstitial injury would differ from risk factors for albuminuria. METHODS: In this cross-sectional study, we compared urine concentrations of IL-18, KIM-1 and albumin-to-creatinine ratio (ACR) in 908 HIV-infected and 289 HIV-uninfected women enrolled in the Women's Interagency HIV Study, utilizing stored urine specimens from visits between 1999 and 2000. RESULTS: After multivariate-adjusted linear regression analysis, mean urine concentrations were higher in HIV-infected individuals by 38% for IL-18 (P<0.0001), 12% for KIM-1 (P=0.081) and 47% for ACR (P<0.0001). Higher HIV RNA level (15% per 10-fold increase; P<0.0001), lower CD4(+) lymphocyte count (8% per doubling; P=0.0025), HCV infection (30%; P=0.00018) and lower high-density lipoprotein (5% per 10 mg/dl; P=0.0024) were each associated with higher IL-18 concentrations. In contrast, hypertension (81%; P<0.0001) and diabetes (47%; P=0.018) were among the strongest predictors of higher ACR, though HIV RNA level (15% per 10-fold increase; P=0.0004) was also associated with higher ACR. CONCLUSIONS: HIV-infected women had more extensive tubulointerstitial and glomerular injury than uninfected women, but the associated factors differed among the urine biomarkers. Combinations of urinary biomarkers should be investigated to further characterize early kidney injury in HIV-infected women.
BACKGROUND: In HIV-infectedwomen, urine concentrations of novel tubulointerstitial injury markers, interleukin-18 (IL-18) and kidney injury marker-1 (KIM-1), are associated with kidney function decline and all-cause mortality. We hypothesized that HIV-infected individuals with preserved kidney filtration function would have more extensive kidney injury, as determined by urine injury markers, compared to the uninfected controls, and that risk factors for tubulointerstitial injury would differ from risk factors for albuminuria. METHODS: In this cross-sectional study, we compared urine concentrations of IL-18, KIM-1 and albumin-to-creatinine ratio (ACR) in 908 HIV-infected and 289 HIV-uninfectedwomen enrolled in the Women's Interagency HIV Study, utilizing stored urine specimens from visits between 1999 and 2000. RESULTS: After multivariate-adjusted linear regression analysis, mean urine concentrations were higher in HIV-infected individuals by 38% for IL-18 (P<0.0001), 12% for KIM-1 (P=0.081) and 47% for ACR (P<0.0001). Higher HIV RNA level (15% per 10-fold increase; P<0.0001), lower CD4(+) lymphocyte count (8% per doubling; P=0.0025), HCV infection (30%; P=0.00018) and lower high-density lipoprotein (5% per 10 mg/dl; P=0.0024) were each associated with higher IL-18 concentrations. In contrast, hypertension (81%; P<0.0001) and diabetes (47%; P=0.018) were among the strongest predictors of higher ACR, though HIV RNA level (15% per 10-fold increase; P=0.0004) was also associated with higher ACR. CONCLUSIONS:HIV-infectedwomen had more extensive tubulointerstitial and glomerular injury than uninfected women, but the associated factors differed among the urine biomarkers. Combinations of urinary biomarkers should be investigated to further characterize early kidney injury in HIV-infectedwomen.
Authors: C R Parikh; J Mishra; H Thiessen-Philbrook; B Dursun; Q Ma; C Kelly; C Dent; P Devarajan; C L Edelstein Journal: Kidney Int Date: 2006-05-17 Impact factor: 10.612
Authors: Chi Yuen Cheung; Kim Ming Wong; Man Po Lee; Yan Lun Liu; Heidi Kwok; Rita Chung; Ka Foon Chau; Chung Ki Li; Chun Sang Li Journal: Nephrol Dial Transplant Date: 2007-06-16 Impact factor: 5.992
Authors: Lynda Anne Szczech; Carl Grunfeld; Rebecca Scherzer; Jesse A Canchola; Charles van der Horst; Stephen Sidney; David Wohl; Michael G Shlipak Journal: AIDS Date: 2007-05-11 Impact factor: 4.177
Authors: Christina M Wyatt; Jonathan A Winston; Carlos D Malvestutto; Dawn A Fishbein; Irina Barash; Alan J Cohen; Mary E Klotman; Paul E Klotman Journal: AIDS Date: 2007-10-01 Impact factor: 4.177
Authors: Kara Wools-Kaloustian; Samir K Gupta; Eva Muloma; Willis Owino-Ong'or; John Sidle; Ryan W Aubrey; Jianzhao Shen; Kirwa Kipruto; Beth E Zwickl; Mitchell Goldman Journal: Nephrol Dial Transplant Date: 2007-08 Impact factor: 5.992
Authors: Simon B Ascher; Rebecca Scherzer; Michelle M Estrella; Michael G Shlipak; Derek K Ng; Frank J Palella; Mallory D Witt; Ken Ho; Michael R Bennett; Chirag R Parikh; Joachim H Ix; Vasantha Jotwani Journal: Am J Nephrol Date: 2019-09-25 Impact factor: 3.754
Authors: Simon B Ascher; Rebecca Scherzer; Arvind Nishtala; Vasantha Jotwani; Carl Grunfeld; Chirag R Parikh; Derek Ng; Ruibin Wang; Frank J Palella; Michael G Shlipak; Michelle M Estrella Journal: J Acquir Immune Defic Syndr Date: 2019-10-01 Impact factor: 3.731
Authors: Simon B Ascher; Rebecca Scherzer; Carmen A Peralta; Phyllis C Tien; Carl Grunfeld; Michelle M Estrella; Alison Abraham; Deborah R Gustafson; Marek Nowicki; Anjali Sharma; Mardge H Cohen; Anthony W Butch; Mary A Young; Michael R Bennett; Michael G Shlipak Journal: Hypertension Date: 2016-12-19 Impact factor: 10.190
Authors: Vasantha Jotwani; Rebecca Scherzer; Michelle M Estrella; Lisa P Jacobson; Mallory D Witt; Frank Palella; Ken Ho; Michael Bennett; Chirag R Parikh; Joachim H Ix; Michael Shlipak Journal: Antivir Ther Date: 2017-01-05
Authors: Yisel M Cantres-Rosario; Valerie Wojna; Rafael Ruiz; Bexaida Diaz; Miriam Matos; Rosa J Rodriguez-Benitez; Elaine Rodriguez; Richard L Skolasky; Yamil Gerena Journal: Front Neurol Date: 2022-06-02 Impact factor: 4.086
Authors: Vasantha Jotwani; Michael G Shlipak; Rebecca Scherzer; Rulan S Parekh; W H Linda Kao; Michael Bennett; Mardge H Cohen; Marek Nowicki; Anjali Sharma; Mary Young; Phyllis C Tien; Chirag R Parikh; Michelle M Estrella Journal: Am J Kidney Dis Date: 2015-04-24 Impact factor: 8.860
Authors: Sanjiv M Baxi; Rebecca Scherzer; Vasantha Jotwani; Michelle M Estrella; Alison G Abraham; Chirag R Parikh; Michael R Bennett; Mardge H Cohen; Marek J Nowicki; Deborah R Gustafson; Anjali Sharma; Mary A Young; Michael G Shlipak Journal: J Acquir Immune Defic Syndr Date: 2017-04-15 Impact factor: 3.731
Authors: Vasantha Jotwani; Rebecca Scherzer; Alison Abraham; Michelle M Estrella; Michael Bennett; Mardge H Cohen; Marek Nowicki; Anjali Sharma; Mary Young; Phyllis C Tien; Joachim H Ix; Mark J Sarnak; Chirag R Parikh; Michael G Shlipak Journal: Clin J Am Soc Nephrol Date: 2014-11-04 Impact factor: 8.237
Authors: S B Ascher; R Scherzer; M M Estrella; A N Muiru; V K Jotwani; C Grunfeld; J Shigenaga; K A Spaulding; D K Ng; D Gustafson; A B Spence; A Sharma; M H Cohen; C R Parikh; J H Ix; M G Shlipak Journal: HIV Med Date: 2021-03-09 Impact factor: 3.094
Authors: G Emerens Wensink; Annelot F Schoffelen; Hugo A Tempelman; Maarten B Rookmaaker; Andy I M Hoepelman; Roos E Barth Journal: PLoS One Date: 2015-08-26 Impact factor: 3.240